Target intelligence / Profile preview

Small conductance calcium-activated potassium channel protein 1 (KCa2.1) (KCa2.1)

Target
KCa2.1
Molecular classification
Ion channel, Potassium channel, Small conductance calcium-activated potassium channel
01

Overview

KCa2.1, also known as Small conductance calcium-activated potassium channel protein 1 (SK1), is a voltage-independent potassium channel that is gated by intracellular calcium ions [1, 5]. It functions as a heterotetramer or homotetramer, with each subunit constitutively bound to calmodulin, which acts as the calcium sensor [1, 5, 14]. KCa2.1 is primarily expressed in the central nervous system and the heart, where it plays a vital role in regulating cellular excitability by contributing to the medium afterhyperpolarization (mAHP) following an action potential [1, 6, 18]. In neurons, this activity helps control firing frequency and synaptic plasticity, making it a target for neurodegenerative diseases and neuropathic pain [2, 8, 11]. In the heart, KCa2.1 is predominantly found in the atria and is involved in the repolarization of the cardiac action potential, with its dysregulation linked to atrial fibrillation [18, 19]. Pharmacological agents such as the bee venom peptide apamin act as blockers, while small molecules like GW542573X and riluzole serve as activators or positive gating modulators to fine-tune channel activity for therapeutic purposes [4, 7, 8].

Other names
SK1KCNN1hSK1SKCa1Potassium calcium-activated channel subfamily N member 1
02

Mechanism of action

Channel blocker, Positive gating modulator, Negative gating modulator

03

Biological functions

Signal transductionNeuronal excitabilityMembrane hyperpolarizationAfterhyperpolarization
04

Disease associations

Neuropathic painAtrial fibrillationNeurodegenerative diseaseEpilepsyAtaxia
05

Safety considerations

SeizuresCNS side effectsOff-target effectsPro-arrhythmic risk
06

Interacting drugs

Apamin

8 more in the full profile.

Beyond the preview

Go deeper on Small conductance calcium-activated potassium channel protein 1 (KCa2.1) (KCa2.1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small conductance calcium-activated potassium channel protein 1 (KCa2.1) (KCa2.1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call